Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
Phase 4
Completed
- Conditions
- Osteogenesis Imperfecta
- Interventions
- Drug: Placebos
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 79
- Registration Number
- NCT00131469
- Locations
- 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
🇺🇸Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Baylor College of Medicine, Department of Molecular and Human Gentics, Houston, Texas, United States
Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome
Not Applicable
Completed
- Conditions
- Metabolic Syndrome XPrediabetic StateInsulin ResistanceMetabolic DiseasesObesity
- Interventions
- Drug: Dietary supplement for weight lossBehavioral: Education and counseling for weight loss
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 79
- Registration Number
- NCT00129792
- Locations
- 🇺🇸
Oregon Health and Science University General Clinical Research Center, Portland, Oregon, United States
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Phase 1
Completed
- Conditions
- DepressionMultiple Sclerosis
- Interventions
- Drug: Fish oil concentrateDrug: Placebo
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 39
- Registration Number
- NCT00122954
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
Not Applicable
Completed
- Conditions
- Pain
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2005-07-21
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 80
- Registration Number
- NCT00121329
- Locations
- 🇺🇸
Planned Parenthood of the Columbia Willamette, Portland, Oregon, United States
Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?
Not Applicable
Completed
- Conditions
- Breakthrough Bleeding
- First Posted Date
- 2005-07-19
- Last Posted Date
- 2005-07-19
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 160
- Registration Number
- NCT00120913
- Locations
- 🇺🇸
OHSU, Portland, Oregon, United States
Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients
Phase 1
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Drug: Salvia officinalis (sage)
- First Posted Date
- 2005-05-11
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 111
- Registration Number
- NCT00110552
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
Phase 1
Completed
- Conditions
- DementiaOxidative StressInflammationAlzheimer's DiseaseHyperlipidemia
- Interventions
- Other: Fish Oil PlaceboDietary Supplement: Fish OilOther: Lipoic Acid PlaceboDietary Supplement: Lipoic Acid
- First Posted Date
- 2004-08-26
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 39
- Registration Number
- NCT00090402
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
Promoting Healthy Lifestyles Among Firefighters
Phase 2
Completed
- Conditions
- Cardiovascular DiseasesCancerPhysical ActivityNutrition
- First Posted Date
- 2000-08-21
- Last Posted Date
- 2014-01-07
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 600
- Registration Number
- NCT00006181
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States